ProVascTec is a pre-clinical stage cell therapy company with a proprietary technology to increase the efficacy of cell therapies by increasing the pay-load delivery and prolonging
Founded in 2023, LEP Biomedical is a pharmaceutical controlled release company with a core mission to simplify and improve post-operative care for patients undergoing ophthalmic su
HAON are developing CanVas-001, a potential world first therapeutic drug for newborn brain injury. Our lead indication for CanVas-001is one of the largest global unmet needs, hypo
Assay Genie provides high-quality In Vivo antibodies to support preclinical and translational research. Our extensive portfolio includes monoclonal and polyclonal antibodies optimi
Celtic Biotech is developing novel candidate therapies for the treatment of solid cancers and pain in humans. Derived from specialised receptor binding proteins found in snake veno
Founded in Dublin in 2015, ATXA Therapeutics Ltd (ATXA) is a clinical-stage pharmaceutical company bringing its proprietary drugs through clinical development in the heart and lung
By Dr. Moayed Hamza/Mr Mark O'Neill FCA
